Pediatric anti-HMGCR necrotizing myopathy: diagnostic challenges and literature review
- 1 June 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Neurological Sciences
- Vol. 41 (10), 3009-3013
- https://doi.org/10.1007/s10072-020-04491-6
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophyNeurology Neuroimmunology & Neuroinflammation, 2019
- Anti-HMGCR MyopathyJournal of Neuromuscular Diseases, 2018
- 224th ENMC International Workshop:Neuromuscular Disorders, 2017
- Anti–3‐hydroxy‐3‐methylglutaryl‐coenzyme a reductase necrotizing myopathy masquerading as a muscular dystrophy in a childMuscle & Nerve, 2017
- Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of PatientsThe Journal of Rheumatology, 2017
- Association of Anti–3‐Hydroxy‐3‐Methylglutaryl‐Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis PatientsArthritis Care & Research, 2017
- Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodiesRheumatology, 2016
- Anti-HMGCR Autoantibodies in European Patients With Autoimmune Necrotizing MyopathiesMedicine, 2014
- Antibody levels correlate with creatine kinase levels and strength in anti–3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase–associated autoimmune myopathyArthritis & Rheumatism, 2012
- Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathyArthritis & Rheumatism, 2010